- call +1-201-465-4211
- email sales@mrinsights.biz
In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections. Pregnancy tests and checks of blood glucose levels are two examples of IVDs.
Scope of the Report:
This report studies the In-vitro Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the In-vitro Diagnostics market by product type and applications/end industries.
High prevalence of chronic and infectious diseases, increasing use of point of care (POC) diagnostics, and surging number of private hospitals and independent testing laboratories are some of the other factors contributing to the growth of the market.
The global In-vitro Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of In-vitro Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Biomérieux
Danaher
Roche Diagnostics
Becton, Dickinson
Bio-Rad Laboratories
Abbott
QIAGEN
Arkray
Sysmex
Ortho Clinical Diagnostics
Siemens
Thermo Fisher Scientific
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Instruments
Reagents
Data Management Systems
Market Segment by Applications, can be divided into
Laboratories
Hospitals
Academia
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 In-vitro Diagnostics Market Overview
1.1 Product Overview and Scope of In-vitro Diagnostics
1.2 Classification of In-vitro Diagnostics by Types
1.2.1 Global In-vitro Diagnostics Revenue Comparison by Types (2017-2023)
1.2.2 Global In-vitro Diagnostics Revenue Market Share by Types in 2017
1.2.3 Instruments
1.2.4 Reagents
1.2.5 Data Management Systems
1.3 Global In-vitro Diagnostics Market by Application
1.3.1 Global In-vitro Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Laboratories
1.3.3 Hospitals
1.3.4 Academia
1.4 Global In-vitro Diagnostics Market by Regions
1.4.1 Global In-vitro Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) In-vitro Diagnostics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) In-vitro Diagnostics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) In-vitro Diagnostics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) In-vitro Diagnostics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) In-vitro Diagnostics Status and Prospect (2013-2023)
1.5 Global Market Size of In-vitro Diagnostics (2013-2023)
2 Manufacturers Profiles
2.1 Biomérieux
2.1.1 Business Overview
2.1.2 In-vitro Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Biomérieux In-vitro Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Danaher
2.2.1 Business Overview
2.2.2 In-vitro Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Danaher In-vitro Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche Diagnostics
2.3.1 Business Overview
2.3.2 In-vitro Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Diagnostics In-vitro Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Becton, Dickinson
2.4.1 Business Overview
2.4.2 In-vitro Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Becton, Dickinson In-vitro Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bio-Rad Laboratories
2.5.1 Business Overview
2.5.2 In-vitro Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bio-Rad Laboratories In-vitro Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abbott
2.6.1 Business Overview
2.6.2 In-vitro Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abbott In-vitro Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.7 QIAGEN
2.7.1 Business Overview
2.7.2 In-vitro Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 QIAGEN In-vitro Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Arkray
2.8.1 Business Overview
2.8.2 In-vitro Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Arkray In-vitro Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sysmex
2.9.1 Business Overview
2.9.2 In-vitro Diagnostics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sysmex In-vitro Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ortho Clinical Diagnostics
2.10.1 Business Overview
2.10.2 In-vitro Diagnostics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ortho Clinical Diagnostics In-vitro Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.11 Siemens
2.11.1 Business Overview
2.11.2 In-vitro Diagnostics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Siemens In-vitro Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.12 Thermo Fisher Scientific
2.12.1 Business Overview
2.12.2 In-vitro Diagnostics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Thermo Fisher Scientific In-vitro Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
3 Global In-vitro Diagnostics Market Competition, by Players
3.1 Global In-vitro Diagnostics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 In-vitro Diagnostics Players Market Share
3.2.2 Top 10 In-vitro Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global In-vitro Diagnostics Market Size by Regions
4.1 Global In-vitro Diagnostics Revenue and Market Share by Regions
4.2 North America In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
4.3 Europe In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
4.5 South America In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
5 North America In-vitro Diagnostics Revenue by Countries
5.1 North America In-vitro Diagnostics Revenue by Countries (2013-2018)
5.2 USA In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
5.3 Canada In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
5.4 Mexico In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
6 Europe In-vitro Diagnostics Revenue by Countries
6.1 Europe In-vitro Diagnostics Revenue by Countries (2013-2018)
6.2 Germany In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
6.3 UK In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
6.4 France In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
6.5 Russia In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
6.6 Italy In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific In-vitro Diagnostics Revenue by Countries
7.1 Asia-Pacific In-vitro Diagnostics Revenue by Countries (2013-2018)
7.2 China In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
7.3 Japan In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
7.4 Korea In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
7.5 India In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
8 South America In-vitro Diagnostics Revenue by Countries
8.1 South America In-vitro Diagnostics Revenue by Countries (2013-2018)
8.2 Brazil In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
8.3 Argentina In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
8.4 Colombia In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue In-vitro Diagnostics by Countries
9.1 Middle East and Africa In-vitro Diagnostics Revenue by Countries (2013-2018)
9.2 Saudi Arabia In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
9.3 UAE In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
9.4 Egypt In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
9.5 Nigeria In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
9.6 South Africa In-vitro Diagnostics Revenue and Growth Rate (2013-2018)
10 Global In-vitro Diagnostics Market Segment by Type
10.1 Global In-vitro Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Global In-vitro Diagnostics Market Forecast by Type (2018-2023)
10.3 Instruments Revenue Growth Rate (2013-2023)
10.4 Reagents Revenue Growth Rate (2013-2023)
10.5 Data Management Systems Revenue Growth Rate (2013-2023)
11 Global In-vitro Diagnostics Market Segment by Application
11.1 Global In-vitro Diagnostics Revenue Market Share by Application (2013-2018)
11.2 In-vitro Diagnostics Market Forecast by Application (2018-2023)
11.3 Laboratories Revenue Growth (2013-2018)
11.4 Hospitals Revenue Growth (2013-2018)
11.5 Academia Revenue Growth (2013-2018)
12 Global In-vitro Diagnostics Market Size Forecast (2018-2023)
12.1 Global In-vitro Diagnostics Market Size Forecast (2018-2023)
12.2 Global In-vitro Diagnostics Market Forecast by Regions (2018-2023)
12.3 North America In-vitro Diagnostics Revenue Market Forecast (2018-2023)
12.4 Europe In-vitro Diagnostics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific In-vitro Diagnostics Revenue Market Forecast (2018-2023)
12.6 South America In-vitro Diagnostics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa In-vitro Diagnostics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure In-vitro Diagnostics Picture
Table Product Specifications of In-vitro Diagnostics
Table Global In-vitro Diagnostics and Revenue (Million USD) Market Split by Product
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
